Session

OAB: What matters in diagnosis and treatment

Thematic Session 04

  • Location:
    Room Amsterdam, North Hall (Level 1)
  • Chairs:
     J-N.L. Cornu, Rouen (FR)
     F. Cruz, Porto (PT)
  • Aims and objectives of this session

    OAB is a common symptom complex that includes urgency, frequency, nocturia and urgency incontinence. Despite the fact that it is highly prevalent in both genders, its cause is still unclear. Tests that may help clinicians to identify the origin of OAB symptoms are still uncertain but need to be explored if the more specific treatments are to be discovered and prescribed. The bother caused by OAB symptoms is crucial for planning a correct management of the condition and this may call for the use of patient-reported outcomes.

State-of-the-art lecture Multiple comorbidity and OAB: What matters to patients and GP's?
 J-N.L. Cornu, Rouen (FR)
State-of-the-art lecture Which urodynamic parameters correlate with OAB severity?
 M.J. Drake, Bristol (GB)
State-of-the-art lecture Biomarkes for OAB
 K. Monastyrskaya, Bern (CH)
Outcomes for medical treatment in OAB
Introduction: OAB - What will make your treatment a success or failure?
 J-N.L. Cornu, Rouen (FR)
OAB: What outcomes are important?
 K. Rademakers, Maastricht (NL)
Patient Reported Outcome Measures (PROMs) in OAB: What are we measuring?
 C. Kelleher, London (GB)
State-of-the-art lecture Innovation in neuromodulation
 S. Elneil, London (GB)